Literature DB >> 33066894

Impact of the Coronavirus Disease Pandemic on the Number of Strokes and Mechanical Thrombectomies: A Systematic Review and Meta-Analysis.

Julius July1, Raymond Pranata2.   

Abstract

BACKGROUND: This systematic review and meta-analysis aimed to evaluate the impact of the coronavirus disease (COVID-19) pandemic on stroke care, including the number of stroke alerts/codes, number of reperfusions, and number of thrombectomies during the pandemic compared to those during the pre-pandemic period.
METHODS: A systematic literature search was performed using the PubMed, EuropePMC, and Cochrane Central databases. The data of interest were the number of strokes, reperfusions, and mechanical thrombectomies during the COVID-19 pandemic versus that during the pre-pandemic period (in a historical comparator group over a specified period of same period length).
RESULTS: The study included 59,233 subjects from 9 studies. Meta-analysis showed that the number of stroke alerts during the pandemic was 64% (56-71%) of that during the pre-pandemic period. The number of reperfusion therapies during the pandemic was 69% (61-77%) of that during the pre-pandemic period. Pooled analysis showed that the number of mechanical thrombectomies performed during the pandemic was 78% (75-80%) of that during the pre-pandemic period. The number of mechanical thrombectomies per stroke patient was higher during the pandemic (OR 1.23 [1.12-1.36], p < 0.001; I2: 0%, p = 0.845).
CONCLUSION: This meta-analysis showed that the number of stroke alerts, reperfusions, and mechanical thrombectomies was reduced by 36%, 31%, and 22%, respectively, during the pandemic. However, the number of patients receiving mechanical thrombectomy per stroke increased.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COVID-19; Cerebrovascular Diseases; Mechanical Thrombectomy; SARS-CoV-2; Stroke

Mesh:

Year:  2020        PMID: 33066894      PMCID: PMC7375276          DOI: 10.1016/j.jstrokecerebrovasdis.2020.105185

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


Introduction

As of 13th July 2020, there have been 12,768,307 cases of coronavirus disease (COVID-19), which has resulted in 566,654 deaths. Although most COVID-19 patients are asymptomatic, a significant proportion develops severe manifestations that may lead to death. Patients with advanced age and preexisting comorbidities are more likely to develop severe disease.2, 3, 4, 5, 6, 7, 8 The incidence of acute conditions such as myocardial infarction was shown to be “reduced” during the pandemic. Because of the looming possibility of in-hospital COVID-19 transmission, people are more reluctant to visit the hospital. This was reflected in a study on patients with myocardial infarction, which showed that 27% of patients avoided hospitals because of the fear of COVID-19 transmission. Similarly, a study showed that the COVID-19 pandemic disrupted prehospital and in-hospital care, resulting in a significant drop in admissions, thrombolysis, and thrombectomy. However, other factors such as decreased pollution during pandemic may decrease myocardial infarction or stroke. , Delays in the prehospital and in-hospital chain may lead to a prolonged time to presentation, beyond the golden hour for reperfusion, which may reduce the number of reperfusion and thrombectomy. Less result may result in increased morbidity and mortality. This systematic review and meta-analysis aimed to evaluate the impact of this pandemic on stroke care, including the number of stroke alerts/codes, number of reperfusions, and number of thrombectomies during the COVID-19 pandemic compared to the pre-pandemic period.

Material and Methods

Search Strategy

A systematic literature search was performed using the keywords “stroke,” “cerebrovascular diseases,” “cerebral infarction,” “brain ischemia,” “stroke alert,” or “thrombectomy” and “COVID-19” or “Coronavirus Disease 2019” or “2019 n-CoV,” or “SARS-CoV-2” or “pandemic” on PubMed, EuropePMC, and Cochrane Central Database. Hand-sampling from potential articles cited by other studies was also used to identify published studies from 1 January 2020 to 8 June 2020. This initial search was performed by two independent researchers, and the resulting discrepancies were solved by discussion. Inclusion and exclusion criteria were then applied to the retrieved records.

Inclusion and Exclusion Criteria

The inclusion criteria for this systematic review and meta-analysis were original articles, research letters, short reports, and case series containing primary data. The data of interest were the number of strokes, reperfusions, and mechanical thrombectomies during the COVID-19 pandemic versus the comparator period. The comparator group was a historical control over a specified period of time (same period length) before the pandemic. The exclusion criteria were preprints, case reports, review articles, and articles in a non-English language.

Data Extraction

Data extraction and quality assessment were performed by two independent researchers using extraction forms for the first author, year of publication, sample size, study design, number of stroke alerts/codes, number of reperfusions, and number of mechanical thrombectomies. Quality assessment was performed using Oxford CEBM Critical Appraisal tool. The number of reperfusions was defined as the number of patients with acute ischemic stroke receiving thrombolysis and mechanical thrombectomy alone or with intra-arterial thrombolysis. Mechanical thrombectomy was defined as revascularization for acute ischemic stroke with either mechanical thrombectomy alone or with the addition of intra-arterial thrombolysis.

Statistical analysis

Meta-analysis of proportion was used to determine the number of stroke alerts/codes, reperfusions, and mechanical thrombectomies during the pandemic compared to that during the historical pre-pandemic control period. STATA 16.0 (StataCorp 2019 LLC) was used to perform the meta-analysis with a random-effects model, regardless of heterogeneity. Heterogeneity was calculated using I2 statistics and Cochran's Q test, in which I2 > 50% or p < 0.10 indicated significant heterogeneity. Assessment for publication bias and meta-regression analysis was not performed because of the limited number of studies (<10 studies).

Results

Study Selection and Characteristics

There were a total of 1,760 records, of which 1,305 remained after removal of duplicates. A total of 1,290 records were excluded after screening the titles and abstracts, leaving 15 eligible studies. After the full texts were screened for eligibility, we excluded 6 more articles for the following reasons: 1) no data on outcome of interest (n = 4), 2) preprint (n = 1), or 3) report was per 100,000 inhabitants (n = 1). We included 9 studies for our qualitative and quantitative analyses [Fig. 1 ]. There were a total of 59,233 subjects from 9 studies. , 14, 15, 16, 17, 18, 19, 20, 21 Characteristics of the included studies are presented in Table 1 .
Fig. 1

Study flow diagram.

Table 1

Characteristics of the included studies

First AuthorStudy DesignLocationSample Size (2020 vs Control)Pandemic PeriodControl PeriodAge (years)Male (%)Mortality (%)
Pop R 2020Multicenter; Retrospective ObservationalAlsace, France174 vs 2881st March 2020 to 31st March 20201st March 2019 to 31st March 2019N/A*N/A*N/A*
Schirmer 2020Multicenter; Prospective and Retrospective ObservationalUnited States163 vs 320February 2020 to March 2020February 2019 to March 2019N/A*N/A*N/A*
Hecht 2020Single Center;Retrospective ObservationalBerlin, Germany18 vs 391st February 2020 to 15th April 20201st February 2019 to 15th April 2019N/A*N/A*N/A*
Yang B 2020Single Center;Retrospective ObservationalBeijing, China21 vs 3423rd January 2020 to 7th March 20201st December 2019 to 14th January 202062.3±12.8 vs 65.2±13.171.4 vs 64.7N/A*
Naccarato 2020Single Center;Retrospective ObservationalTrieste, Italy16 vs 299th March 2020to 9th April 20209th March 2019 to 9th April 201977 (67–81) vs 78 (70–85)37.5 vs 41.412 vs 10
Teo 2020Single Center;Retrospective ObservationalHong Kong, China73 vs 8923rd January 2020 to 24th March 202023rd January 2019 to 24th March 201970.1±16.2 vs 73.6±13.143.8 vs 50.6N/A*
Zhao 2020Multicenter; Retrospective ObservationalChina (National)21581 vs 34725February 2020February 2019N/A*N/A*N/A*
Rudilosso 2020Multicenter; Retrospective ObservationalCatalonia, Spain68 vs 83March 2020March 201969 (64–73) vs 75 (73–80)56 vs 5511.8 vs 9.2
Kerleroux 2020Multicenter; Prospective and Retrospective ObservationalFrance (National)668 vs 84415th February 2020 to 30th March 202015th February 2019 to 30th March 2019N/A*N/A*N/A*

Data in the table are presented by grouping during the pandemic period vs. the pre-pandemic period.

Data was not presented by grouping of the pandemic period vs. the pre-pandemic period.

Study flow diagram. Characteristics of the included studies Data in the table are presented by grouping during the pandemic period vs. the pre-pandemic period. Data was not presented by grouping of the pandemic period vs. the pre-pandemic period.

Stroke Alerts/Codes

The meta-analysis showed that the number of stroke alerts during the pandemic was 64% (56–71%) of that during the pre-pandemic period [Fig. 2 ].
Fig. 2

Forest plot showing the number of stroke alerts/codes during the pandemic compared with the pre-pandemic period.

Forest plot showing the number of stroke alerts/codes during the pandemic compared with the pre-pandemic period.

Reperfusion Therapy

The number of reperfusion therapies undertaken during the pandemic was 69% (61-77%) of that during the pre-pandemic period [Fig. 3 ].
Fig. 3

Forest plot showing the number of reperfusion therapies during the pandemic compared with the pre-pandemic period.

Forest plot showing the number of reperfusion therapies during the pandemic compared with the pre-pandemic period.

Mechanical Thrombectomy

Pooled analysis showed that the number of mechanical thrombectomies performed during the pandemic was 78% (75–80%) of that during the pre-pandemic period [Fig. 4 ]. However, the number of mechanical thrombectomies per stroke patient was higher during the pandemic (OR 1.23 [1.12–1.36], p < 0.001; I2: 0%, p = 0.845).
Fig. 4

Forest plot showing the number of mechanical thrombectomies during the pandemic compared with the pre-pandemic period

Forest plot showing the number of mechanical thrombectomies during the pandemic compared with the pre-pandemic period

Discussion

A meta-analysis of 9 studies showed that the number of stroke alerts/codes, reperfusions, and mechanical thrombectomies was less during the pandemic period than during the pre-pandemic period. However, the number of patients receiving mechanical thrombectomy per stroke increased. The number of strokes was lower during the pandemic; this might be explained by hospital avoidance due to fear of contracting the COVID-19 virus. Nevertheless, further research is needed to better understand the reasons for not seeking care. It should be noted that COVID-19 is associated with coagulopathy , and may increase the risk of stroke. Although the number of COVID-19-related stroke cases is unclear—along with the non-compliance/non-adherence to chronic medications (due to accessibility or drug rumours unproven to be true) and sedentary lifestyle—the incidence of stroke might actually be higher than is usual. Reduction in the number of strokes in this pooled analysis reflects the unmet need for medical attention. However, reduced pollution due to lockdown and other restriction, shift in dietary patterns such as decreased consumption of high-sodium, fast-food intake, may lead to a decreased acute cardio-cerebrovascular events related to pollution. , Disruption in pre-hospital and in-hospital care may lead to delayed onset-to-door time. Teo et al. showed that only 54.8% of the patients were attended to within 4.5 h during the pandemic compared to 71.9% during the pre-pandemic period. Delayed presentation may lead to a reduced number of salvageable areas and also reduce the number of patients eligible for thrombolysis. , Our meta-analysis showed that the number of reperfusion episodes during the pandemic was only two-third of that during the pre-pandemic period. Our result strengthens the conclusion of prior observation that showed marked fall in stroke presentations and services due to COVID-19 in April 2020. , Mechanical thrombectomy—which carries the risk of transmission to health care workers—has become the procedure of choice in the late presenters. The absolute number of mechanical thrombectomies performed was reduced; however, the number of patients receiving thrombectomy per patient with a stroke actually increased. This is possibly because of an increase in late presenters. Another possibility could be due to differences in proportions of patients with large vessel occlusion that are eligible for thrombectomy, or a greater tendency of more severe strokes, also those who would be candidates for thrombectomy, to present to emergency department during the pandemic compared to those with less severe stroke. Regardless of severity of stroke, people experiencing symptoms of cardio-cerebrovascular diseases should be encouraged to seek emergency medical care. The limitation of this systematic review and meta-analysis is that the limited data on clinical outcomes prohibit us from calculating the impact of the pandemic in terms of morbidity and mortality. The out-of-hospital deaths in specific regions, which may provide insight on patients with unmet medical needs, cannot be addressed in this meta-analysis. There might be an increasing trend of mechanical thrombectomy due to advances in technology and an increase/decrease in the real stroke incidence. There is no data on other possible factors such as pollution and dietary patterns that may affect the incidence of stroke. The data on proportion of patients with large vessel occlusion eligible for thrombectomy during pandemic compared to pre-pandemic is not thoroughly available.

Conclusion

This meta-analysis showed that the number of stroke alerts/codes, reperfusions, and mechanical thrombectomies was reduced by 36%, 31%, and 22%, respectively, during the pandemic. However, the number of patients receiving mechanical thrombectomy per stroke increased.

Ethics approval and consent to participate

Not Applicable

Consent for publication

Not Applicable

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Conflict of interest

The authors declare that they have no competing interests.

Funding

None

Author's Contribution

J.J. and R.P. conceived and designed the study and drafted the manuscript. J.J. and R.P. acquired the data and drafted the manuscript. J.J. and R.P. performed data extraction, interpreted the data, and performed extensive research on the topic. J.J and R.P. performed the statistical analysis. All authors contributed to the writing of the manuscript.
  29 in total

1.  A time-to-event analysis on air pollutants with the risk of cardiovascular disease and mortality: A systematic review and meta-analysis of 84 cohort studies.

Authors:  Raymond Pranata; Rachel Vania; Alexander Edo Tondas; Budhi Setianto; Anwar Santoso
Journal:  J Evid Based Med       Date:  2020-03-13

2.  COVID-19 and stroke-A global World Stroke Organization perspective.

Authors:  Hugh S Markus; Michael Brainin
Journal:  Int J Stroke       Date:  2020-04-29       Impact factor: 5.266

3.  C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis.

Authors:  Ian Huang; Raymond Pranata; Michael Anthonius Lim; Amaylia Oehadian; Bachti Alisjahbana
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

4.  The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.

Authors:  Raymond Pranata; Hikmat Permana; Ian Huang; Michael Anthonius Lim; Nanny Natalia M Soetedjo; Rudi Supriyadi; Arto Yuwono Soeroto; Amir Aziz Alkatiri; Doni Firman; Antonia Anna Lukito
Journal:  Diabetes Metab Syndr       Date:  2020-06-27

5.  Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression.

Authors:  Raymond Pranata; Michael Anthonius Lim; Ian Huang; Sunu Budhi Raharjo; Antonia Anna Lukito
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Apr-Jun       Impact factor: 1.636

6.  Impact of COVID-19 pandemic on ST-elevation myocardial infarction in a non-COVID-19 epicenter.

Authors:  Tarek A Hammad; Melanie Parikh; Nour Tashtish; Cynthia M Lowry; Diane Gorbey; Farshad Forouzandeh; Steven J Filby; William M Wolf; Marco A Costa; Daniel I Simon; Mehdi H Shishehbor
Journal:  Catheter Cardiovasc Interv       Date:  2020-06-01       Impact factor: 2.585

7.  Impact of the COVID-19 outbreak on acute stroke pathways - insights from the Alsace region in France.

Authors:  R Pop; V Quenardelle; A Hasiu; D Mihoc; F Sellal; M H Dugay; P A Lebedinsky; E Schluck; A LA Porta; S Courtois; R Gheoca; V Wolff; R Beaujeux
Journal:  Eur J Neurol       Date:  2020-06-03       Impact factor: 6.089

8.  Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression.

Authors:  Ian Huang; Michael Anthonius Lim; Raymond Pranata
Journal:  Diabetes Metab Syndr       Date:  2020-04-17

9.  Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis.

Authors:  Ian Huang; Raymond Pranata
Journal:  J Intensive Care       Date:  2020-05-24

10.  Has COVID-19 played an unexpected "stroke" on the chain of survival?

Authors:  Marcello Naccarato; Ilario Scali; Sasha Olivo; Miloš Ajčević; Alex Buoite Stella; Giovanni Furlanis; Carlo Lugnan; Paola Caruso; Alberto Peratoner; Franco Cominotto; Paolo Manganotti
Journal:  J Neurol Sci       Date:  2020-05-06       Impact factor: 3.181

View more
  15 in total

1.  Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke.

Authors:  Gregory Y H Lip; Deirdre A Lane; Radosław Lenarczyk; Giuseppe Boriani; Wolfram Doehner; Laura A Benjamin; Marc Fisher; Deborah Lowe; Ralph L Sacco; Renate Schnabel; Caroline Watkins; George Ntaios; Tatjana Potpara
Journal:  Eur Heart J       Date:  2022-07-07       Impact factor: 35.855

2.  Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression.

Authors:  Indriwanto Sakidjan Atmosudigdo; Raymond Pranata; Michael Anthonius Lim; Joshua Henrina; Emir Yonas; Rachel Vania; Basuni Radi
Journal:  J Clin Exp Hepatol       Date:  2021-02-08

3.  Challenge in diagnosis of COVID-19 in hemodialysis patient: a case report and brief review of the literature.

Authors:  Rizky Andhika; Afiatin Makmun; Yovita Hartantri; Indra Wijaya; Ian Huang
Journal:  CEN Case Rep       Date:  2021-01-16

4.  Stroke management during the coronavirus disease 2019 (COVID-19) pandemic: experience from three regions of the north east of Italy (Veneto, Friuli-Venezia-Giulia, Trentino-Alto-Adige).

Authors:  Paolo Manganotti; Marcello Naccarato; Ilario Scali; Manuel Cappellari; Bruno Bonetti; Alessandro Burlina; Emanuele Turinese; Sabrina Bogo; Francesco Teatini; Enrica Franchini; Giorgio Caneve; Giampietro Ruzza; Anna Gaudenzi; Roberto Bombardi; Giulio Bozzato; Roberta Padoan; Carolina Gentile; Michele Rana; Michelangelo Turazzini; Danese Alessandra; Francesco Brigo; Raffaele Nardone; Rocco Quatrale; Elisabetta Menegazzo; Maela Masato; Stefano Novello; Paolo Passadore; Antonio Baldi; Luca Valentinis; Claudio Baracchini; Alessio Pieroni; Anna Maria Basile; Claudio Semplicini; Silvio Piffer; Bruno Giometto; Simone Tonello; Domenico Marco Bonifatti; Simone Lorenzut; Giovanni Merlino; Maria Rosaria Valente; Francesco Paladin; Agnese Tonon; Cristina de Luca; Francesco Perini; Sandro Centonze; Paolo Bovi
Journal:  Neurol Sci       Date:  2021-03-04       Impact factor: 3.307

5.  Impact of COVID-19 pandemic on haemorrhagic stroke admissions: a systematic review and meta-analysis.

Authors:  Yijie You; Yunlian Niu; Fengbing Sun; Jian Zhang; Sheng Huang; Peiyuan Ding; Xuhui Wang
Journal:  BMJ Open       Date:  2021-12-14       Impact factor: 2.692

6.  Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression.

Authors:  Indriwanto Sakidjan Atmosudigdo; Michael Anthonius Lim; Basuni Radi; Joshua Henrina; Emir Yonas; Rachel Vania; Raymond Pranata
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2021-03-24

7.  Experiences of a neurosurgical center in the United Kingdom during the COVID-19 pandemic.

Authors:  Ahmed Nabil ElGhamry; Nithish Jayakumar; Nicholas Ross
Journal:  Surg Neurol Int       Date:  2021-06-07

8.  A meta-analysis of the global impact of the COVID-19 pandemic on stroke care & the Houston Experience.

Authors:  Sujan T Reddy; Nikunj Satani; Jennifer E S Beauchamp; Sudhakar Selvaraj; Suja S Rajan; Mohammad H Rahbar; Amirali Tahanan; Sori Kim; Travis Holder; Xiaoqian Jiang; Luyao Chen; Haris Kamal; Hari Kishan R Indupuru; Tzu-Ching Wu; Sean I Savitz
Journal:  Ann Clin Transl Neurol       Date:  2021-02-22       Impact factor: 5.430

9.  Dipeptidyl peptidase-4 (DPP-IV) inhibitor was associated with mortality reduction in COVID-19 - A systematic review and meta-analysis.

Authors:  Ahmad Fariz Malvi Zamzam Zein; Wilson Matthew Raffaello
Journal:  Prim Care Diabetes       Date:  2021-12-13       Impact factor: 2.459

10.  Influence of coronavirus disease 2019 (COVID-19) on working flow, safety and efficacy outcome of mechanical thrombectomy for acute ischemic stroke with large vessel occlusion.

Authors:  Xiaochuan Huo; Xuan Sun; Dapeng Mo; Feng Gao; Ning Ma; Yilong Wang; Yongjun Wang; Zhongrong Miao
Journal:  Interv Neuroradiol       Date:  2021-05-18       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.